LCN2 and age-related macular degeneration: To our knowledge, CSCR is the only ocular disease associated with decreased LCN2 level, and therefore LCN2 could be potentially used as a biomarker for CSCR, particularly in atypical cases or those where the differential diagnosis with AMD is challenging.